
CYduct Diagnostics, Inc. (CYDX)
CYDX Stock Price Chart
Explore CYduct Diagnostics, Inc. interactive price chart. Choose custom timeframes to analyze CYDX price movements and trends.
CYDX Company Profile
Discover essential business fundamentals and corporate details for CYduct Diagnostics, Inc. (CYDX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
14 Jan 2000
Employees
3.00
Website
https://www.solosendoscopy.comCEO
Dom L. Gatto
Description
CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.
CYDX Financial Timeline
Browse a chronological timeline of CYduct Diagnostics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2023
EPS came in at -$0.02 , while revenue for the quarter reached $12.30K .
Stock split effective on 1 Dec 2020
Shares were split 1 : 250 , changing the number of shares outstanding and the price per share accordingly.
CYDX Stock Performance
Access detailed CYDX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.